Compounds That Target MAPK15

mitogen-activated protein kinase 15 · 29 compounds in BiohacksAI corpus

MAPK15 (mitogen-activated protein kinase 15) is a biological target with 29 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAPK15 modulation for therapeutic and biohacking applications.

View MAPK15 target page →UniProt: Q8TD08 ↗

Most Studied Compounds for MAPK15

Sorafenib

300+

studies

Harmaline

300+

studies

Sp600125

117+

studies

All 29 Compounds — Ranked by Evidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Doramapimod

4.06

confidence

Quizartinib

3.99

confidence

Bms 387032

3.47

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Gilteritinib

3.40

confidence

Linifanib

3.33

confidence

At 7519

3.33

confidence

Jnj 7706621

3.09

confidence

Lestaurtinib

3.04

confidence

Ruboxistaurin

2.94

confidence

R 406

2.83

confidence

K 252a

2.83

confidence

Pf 00562271

2.77

confidence

Bms 345541

2.71

confidence

Kw 2449

2.64

confidence

Gsk 690693

2.64

confidence

Ast 487

2.56

confidence

Zotiraciclib

2.56

confidence

Rebastinib

2.20

confidence

Enzastaurin

2.08

confidence

Rg 547

2.08

confidence

Sra 737

1.95

confidence

Sel 120 Free Base

1.95

confidence

Sorafenib

300+

studies

1.79

confidence

Harmaline

300+

studies

0.69

confidence

Sp600125

117+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAPK15 (mitogen-activated protein kinase 15). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAPK15 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.